Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Journal of Medical Economics|February 9, 2012
Economic evaluation of tocilizumab combination in the treatment of moderate-to-severe rheumatoid arthritis in ItalyAlexander Diamantopoulos, Maurizio Benucci, Stefano Capri, et al.
Vaccine|March 4, 2010
The Health Technology Assessment of bivalent HPV vaccine Cervarix in ItalyGiuseppe La Torre, Chiara de Waure, Giacomina Chiaradia, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Atherogenic Dyslipidemias: Unmet Needs and the Therapeutic Potential of Emerging and Novel Approaches and DrugsAlessandra Romandini, Damiano Baldassarre, Stefano Genovese, et al.
International Journal of Technology Assessment in Health Care|July 11, 2018
DEFINING INNOVATION WITH RESPECT TO NEW MEDICINES: A SYSTEMATIC REVIEW FROM A PAYER PERSPECTIVEOriol de Solà-Morales, David Cunningham, Mathias Flume, et al.
Human Vaccines|August 26, 2011
Guidance for future HTA applications to vaccines: the HPV lessonGiuseppe La Torre, Chiara de Waure, Giacomina Chiaradia, et al.
Journal of Market Access & Health Policy|May 27, 2016
Feasibility and attractiveness of indication value-based pricing in key EU countriesMathias Flume, Marc Bardou, Stefano Capri, et al.
Human Vaccines & Immunotherapeutics|January 19, 2012
Economic value of influenza vaccinationChiara de Waure, Maria Assunta Veneziano, Chiara Cadeddu, et al.
Journal of Market Access & Health Policy|July 5, 2023
Budget impact analysis for avatrombopag in the treatment of chronic primary immune thrombocytopenia in adult patients refractory to other treatmentsAndrea Aiello, Elisa Elena Mariano, Mariangela Prada, et al.
Pageof 4